N4 Pharma PLC - Asset Resilience Ratio

Latest as of December 1990: 0.13%

N4 Pharma PLC (N4P) has an Asset Resilience Ratio of 0.13% as of December 1990. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

GBX20.00K

≈ $2.43 USD Cash + Short-term Investments

Total Assets

GBX15.85 Million

≈ $1.93K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1990–2016)

This chart shows how N4 Pharma PLC's Asset Resilience Ratio has changed over time. Check N4 Pharma PLC (N4P) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down N4 Pharma PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see N4P stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX20.00K	0.13%
Total Liquid Assets	GBX20.00K	0.13%

Asset Resilience Insights

Limited Liquidity: N4 Pharma PLC maintains only 0.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

N4 Pharma PLC Industry Peers by Asset Resilience Ratio

Compare N4 Pharma PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	15.57%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%

Annual Asset Resilience Ratio for N4 Pharma PLC (1990–2016)

The table below shows the annual Asset Resilience Ratio data for N4 Pharma PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2016-12-31	20.75%	GBX232.00K ≈ $28.23	GBX1.12 Million ≈ $136.03	+20.63pp
1990-12-31	0.13%	GBX20.00K ≈ $2.43	GBX15.85 Million ≈ $1.93K	--

pp = percentage points

About N4 Pharma PLC

LSE:N4P UK Drug Manufacturers - Specialty & Generic

Market Cap

$48.10K

GBX395.33 Million GBX

Market Cap Rank

#31498 Global

#1204 in UK

Share Price

GBX0.48

Change (1 day)

+0.00%

52-Week Range

GBX0.43 - GBX0.73

All Time High

GBX32.90